Michael Gerken

3.6k total citations
133 papers, 2.3k citations indexed

About

Michael Gerken is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Gerken has authored 133 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 39 papers in Surgery and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Gerken's work include Colorectal Cancer Surgical Treatments (20 papers), Colorectal Cancer Screening and Detection (18 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Michael Gerken is often cited by papers focused on Colorectal Cancer Surgical Treatments (20 papers), Colorectal Cancer Screening and Detection (18 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Michael Gerken collaborates with scholars based in Germany, United Kingdom and United States. Michael Gerken's co-authors include Monika Klinkhammer‐Schalke, Michaela Kreuzer, Lothar Kreienbrock, Joachim Heinrich, Hans J. Schlitt, Martin Loss, Christina Hackl, Peter J. Neumann, Alois Fürst and Jürgen Wellmann and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Michael Gerken

117 papers receiving 2.2k citations

Peers

Countries citing papers authored by Michael Gerken

Since Specialization

Citations

This map shows the geographic impact of Michael Gerken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gerken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gerken more than expected).

Fields of papers citing papers by Michael Gerken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gerken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gerken. The network helps show where Michael Gerken may publish in the future.

Co-authorship network of co-authors of Michael Gerken

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gerken. A scholar is included among the top collaborators of Michael Gerken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gerken. Michael Gerken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased PD‐1/PD‐L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never‐Smokers and Never‐Drinkers 2024 ·Head & Neck ·(unknown), (unknown), Annette Gärtner, Gero Brockhoff, (unknown), (unknown), (unknown), (unknown), Richard J. Bauer, Michael Gerken, Torsten E. Reichert, Tobias Ettl, Florian Weber	0
2	Die Behandlung in zertifizierten Brustkrebszentren verbessert die Überlebenschancen von Patientinnen mit Brustkrebs 2024 ·Senologie - Zeitschrift für Mammadiagnostik und -therapie* ·Olaf Schoffer, Pauline Wimberger, Michael Gerken, (unknown), Christoph Bobeth, M Rößler, Patrik Dröge, (unknown), Christian Günster, (unknown), Theresa Link, Anton Scharl, Elisabeth C. Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt	1
3	How accurate is clinical prognostication by oncologists during routine practice in a general hospital and can it be improved by a specific prognosis training programme: a prospective interventional study 2024 ·BMJ Open ·(unknown), (unknown), Michael Gerken, Alexander Crispin, Jan Braess	0
4	Transanal total mesorectal excision: short- and long-term results of four certified colorectal cancer centers in Germany 2024 ·International Journal of Colorectal Disease ·(unknown), Michael Gerken, (unknown), (unknown), Matthias Biebl, Andreas D. Rink, Werner Kneist, Felix Aigner, (unknown), Alois Fürst	0
5	Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer 2024 ·Geburtshilfe und Frauenheilkunde ·Olaf Schoffer, Pauline Wimberger, Michael Gerken, (unknown), Christoph Bobeth, M Rößler, Patrik Dröge, (unknown), Christian Günster, (unknown), Theresa Link, Anton Scharl, Elisabeth C. Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt	6
6	Endometrial Cancer – Long-Term Survival in Certified Cancer Centers and Non-Certified Hospitals 2024 ·Geburtshilfe und Frauenheilkunde ·(unknown), (unknown), Michael Gerken, Olaf Schoffer, Pauline Wimberger, (unknown), Christoph Bobeth, M Rößler, Patrik Dröge, (unknown), Christian Günster, (unknown), Theresa Link, (unknown), Thomas Papathemelis, Olaf Ortmann, Jochen Schmitt, Monika Klinkhammer‐Schalke	3
7	Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma—Data from a Population-Based Cohort Study Applying Propensity Score Matching 2023 ·Biomedicines ·Steffen Spoerl, Michael Gerken, (unknown), Silvia Spoerl, Christian Kirschneck, Stefanie Wolf, (unknown), Nils Ludwig, Niklas Biermann, Torsten E. Reichert, Gerrit Spanier	3
8	Methodik und Zuordnungserfolg eines Linkage von Daten klinischer Krebsregister mit Abrechnungsdaten gesetzlicher Krankenkassen 2023 ·Das Gesundheitswesen ·Christoph Bobeth, (unknown), M Rößler, (unknown), Michael Gerken, Christian Günster, Patrik Dröge, (unknown), Monika Klinkhammer‐Schalke, Jochen Schmitt, Olaf Schoffer	6
9	Chirurgische Therapie des Adenokarzinoms des ösophagogastralen Übergangs Typ II 2022 ·Die Chirurgie ·(unknown), Michael Gerken, Christiane J. Bruns, Monika Klinkhammer‐Schalke, Armin Pauer, Pompiliu Piso	0
10	Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in Germany 2021 ·Surgical Endoscopy ·(unknown), (unknown), (unknown), Michael Gerken, Monika Klinkhammer‐Schalke, Alois Fürst	5
11	The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients 2020 ·Cancer Letters ·Gerrit Spanier, (unknown), (unknown), (unknown), Sandra Schmidhofer, Almut Brand, Johannes K. Meier, Steffen Spoerl, Rosemarie Krupar, Petra Rümmele, Peter J. Siska, Kathrin Renner, Katrin Peter, Michael Gerken, Philipp Beckhove, Torsten E. Reichert, Marina Kreutz, Katrin Singer	9
12	Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy 2020 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Anton Scharl, Atanas Ignatov, Olaf Ortmann, Elisabeth C. Inwald, Thomas Hildebrandt, Michael Gerken, Monika Klinkhammer‐Schalke, Sophia Scharl, Thomas Papathemelis	9
13	Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers 2020 ·BMC Psychology ·Christiane Reinert, Michael Gerken, (unknown), Katharina Krueger, Monika Klinkhammer‐Schalke, (unknown), Oliver Koelbl, Martin Proescholdt, Markus J. Riemenschneider, Tobias Pukrop, Elisabeth Bumes, Markus Hutterer, Peter Hau	14
14	Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry 2019 ·Archives of Gynecology and Obstetrics ·(unknown), Olaf Ortmann, Michael Gerken, Monika Klinkhammer‐Schalke, Oliver Koelbl, Elisabeth C. Inwald	5
15	Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects 2018 ·BMC Cancer ·Stefan Munker, Michael Gerken, (unknown), Claudia Ott, Elisabeth Schnoy, Stefan Fichtner‐Feigl, Philipp Wiggermann, Martin Vogelhuber, Wolfgang Herr, Christian Stroszczynski, Hans J. Schlitt, Matthias Evert, Michael Reng, Monika Klinkhammer‐Schalke, Andreas Teufel	42
16	Use of statins or NSAIDs and survival of patients with high-grade glioma 2018 ·PLoS ONE ·Corinna Seliger, (unknown), Michael Gerken, Christian A. Luber, Martin Proescholdt, Markus J. Riemenschneider, Michael F. Leitzmann, Peter Hau, Monika Klinkhammer‐Schalke	25
17	Patients with Localised Prostate Cancer (T1 - T2) Show Improved Overall Long-Term Survival Compared to the Normal Population 2011 ·Journal of Cancer ·M.J. Mathers, Stephan Roth, Monika Klinkhammer‐Schalke, Michael Gerken, Ferdinand Hofstaedter, Stefan Wilm, Theodor Klotz	9
18	Onkologie und Männergesundheit - Bedeutung einer interdisziplinären onkologischen Nachsorge bei Männern am Beispiel von unabhängigen Zweittumoren nach urologischem Primärtumor 2005 ·Journal für Kardiologie (Krause & Pachernegg GmbH) ·(unknown), (unknown), Michael Gerken, Ferdinand Hofstädter, M.J. Mathers	0
19	Case-Control Study on Lung Cancer and Residential Radon in Western Germany 2001 ·American Journal of Epidemiology ·Lothar Kreienbrock, Michaela Kreuzer, Michael Gerken, (unknown), Jürgen Wellmann, G. Keller, H.-Erich Wichmann	102
20	Histopathologic findings of lung carcinoma in German uranium miners 2000 ·Cancer ·Michaela Kreuzer, (unknown), (unknown), Michael Gerken, Bernd Grosche, Thorsten Wiethege, H-Erich Wichmann	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact